biotech · Esophageal Squamous Cell Carcinoma
Jiangsu Alphamab Biopharmaceuticals
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Jiangsu Alphamab Biopharmaceuticals clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Jiangsu Alphamab Biopharmaceuticals projects
1 ClinicalTrials.gov programs sponsored by Jiangsu Alphamab Biopharmaceuticals.
Jiangsu Alphamab Biopharmaceuticals has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Jiangsu Alphamab Biopharmaceuticals have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.